Nanxin Pharmaceutical (688189.SH): Guanzhou Qianyuan plans to reduce its shareholding by no more than 3%

Tencent Finance News, Nanxin Pharmaceutical (688189.SH) announced that, due to funding needs, Guangzhou Qianyuan plans to reduce its holdings of the company's shares through centralized bidding and block trading. The reduction plan will start fifteen trading days after disclosure and will be completed within three months, with a total reduction of not more than 8.232 million shares, not exceeding 3% of the company's total share capital.